NCT00244140 - Ultravist: Safety and Efficacy in Computed Tomography of Head and Body | Biotech Hunter

Enrollment

435

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Computed TomographyDiagnostic Imaging

Interventions

DRUG

Iopromide 370 mg I/mL

Iopromide (Ultravist 370 mg I/mL) administered intravenously

DRUG

Iopromide 300 mg I/mL

Iopromide (Ultravist 300 mg I/mL) administered intravenously

Trial Locations (23)

10016

New York

17822

Danville

21287

Baltimore

29425

Charleston

30303

Atlanta

30322

Atlanta

32308

Tallahassee

33101

Miami

44195

Cleveland

48201

Detroit

60201

Evanston

85711

Tucson

02114-2696

Boston

02115

Boston

02118

Boston

48109-0030

Ann Arbor

11794-8460

Stony Brook

Unknown

Medellín

Bogotá

Mumbai-400026

Tamil Nadu

110-744

Seoul

138-736

Seoul